Social, health and drug use characteristics of primary crack users in three mid-sized communities in British Columbia, Canada

Drugs: Education, Prevention and Policy

Volumn 17, Issue 4, 2010, Pages 333-353

  Fischer, Benedikt ^a,b   Rudzinski, Katherine ^b   Ivsins, Andrew ^c   Gallupe, Owen ^a   Patra, Jayadeep ^b   Krajden, Mel ^d,e  

^a SIMON FRASER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954229834     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687630903357700     Document Type: Article

References (100)

1. Baumer, E., Lauritsen, J., Rosenfeld, R., & Wright, R. (1998). The influence of crack cocaine on robbery, burglary and homicide rates: A cross-city longitudinal analysis. Journal of Research in Crime and Delinquency, 35, 316-340.
2. Bennett, T., Holloway, K., & Farrington, D. (2008). The statistical association between drug misuse and crime: A meta-analysis. Aggression and Violent Behavior, 13, 107-118.
3. Best, D., Harris, J., Gossop, M., Farrell, M., Finch, E., Noble, A., et al. (2000). Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment. Drug and Alcohol Review, 19, 9-16.
4. Booth, R. E., Kwiatkowski, C. F., & Chitwood, D. D. (2000). Sex related HIV risk behaviors: Differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug and Alcohol Dependence, 58, 219-226.
5. Borders, T., & Booth, B. (2007). Rural, suburban, and urban variations in alcohol consumption in the United States: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Rural Health, 23, 314-321.
6. Boyd, S., Johnson, J., & Moffat, B. (2008). Opportunities to learn and barriers to change: Crack cocaine use in the Downtown Eastside of Vancouver. Harm Reduction Journal, 5, 1-12.
7. Bruggmann, P., Falcato, L., Dober, S., Helbling, B., Keiser, O., Negro, F., et al. (2008). Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients. Journal of Viral Hepatitis, 15, 747-752.
8. Buxton, J., Rothon, D., Durigon, M., Lem, M., Tu, A., Remple, V., et al. (2009). Hepatitis C and HIV prevalence using oral mucosal transudate, and reported drug use and sexual behaviours of youth in custody in British Columbia. Canadian Journal of Public Health, 100, 121-124.
9. Castells, X., Casas, M., Vidal, X., Bosch, R., Roncero, C., Ramos-Quiroga, J., et al. (2007). Efficay of central nervous system stimulant treatment for cocaine dependence: A systematic review and meta-analysis of randomized controlled clinical trials. Addiction, 102, 1871-1877.
10. CCENDU (2003a). 2002 National report: Drug trends and the Canadian Community Epidemiology Network on Drug Use (CCENDU). Ottawa: Canadian centre on substance abuse.
11. CCENDU (2003b). Vancouver site report for the Canadian Community Epidemiology Network On Drug Use (CCENDU). Ottawa: Canadian centre on substance abuse.
12. Chase Project Team (2005). Community Health and Safety Evaluation (CHASE) project: Final report (Rep. No. http://chase.hivnet.ubc.ca/project/pubdocs/ CHASE-Reports/CHASE-Final-Report.pdf). Vancouver: Chase Project Team.
13. Corneil, T., Kuyper, L., Shoveller, J., Hogg, R., Li, K., Spittal, P., et al. (2006). Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health & Place, 12, 79-85.
14. Cross, J., Johnson, B., Davis, W. R., & Liberty, H. J. (2001). Supporting the habit: Income generation activities of frequent crack users compared with frequent users of other hard drugs. Drug and Alcohol Dependence, 64, 191-201.
15. Dalgard, O. (2005). Follow-up studies of treatment for hepatitis C virus infection among injection drug users. Clinical Infectious Diseases, 40(Suppl 5), 336-8.
16. Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51, 253-262.
17. Darke, S., & Hall, W. (2003). Heroin overdose: Research and evidence-based intervention. Journal of Urban Health, 80, 189-200.
18. Day, C., Conroy, E., Lowe, J., Page, J., & Dolan, K. (2006). Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health, 14, 120-125.
19. DeBeck, K., Shannon, K., Wood, E., Li, K., Montaner, J., & Kerr, T. (2007). Income generating activities of people who inject drugs. Drug and Alcohol Dependence, 91, 50-56.
20. DeHovitz, J., Kelly, P., Feldman, J., Sierra, M., Clarke, L., Bromberg, J., et al. (1994). Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. American Journal of Epidemiology, 140, 1125-1134.
21. Dennison, S. (2005). Substance use disorders in individuals with co-occurring psychiatric disorders. In J. Lowinson, P. Ruiz, R. Millman & J. Langrod (Eds.), Substance abuse a comprehensive textbook (4th ed., pp. 904-912). Philadelphia: Lippincott Williams & Wilkins.
22. Edlin, B. R., Irwin, K. L., Faruque, S., McCoy, C. B., Word, C., Serrano, Y., et al. (1994). Intersecting epidemics: Crack cocaine use and HIV infection among young inner-city young adults. The New England Journal of Medicine, 331, 1422-1427.
23. Edlin, B. R., Kresina, T. F., Raymond, D. B., Carden, M. R., Gourevitch, M. N., Rich, J. D., et al. (2005). Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clinical Infectious Diseases, 40(Suppl. 5), S276-S285.
24. EMCDDA (2007). EMCDDA European Monitoring Centre for Drugs and Drug Addiction selected issue 2007 - Cocaine and crack cocaine: A growing public health concern. Luxembourg: Office for Official Publications of the European Communities.
25. Falck, R. S., Wang, J., Siegal, H. A., & Carlson, R. G. (2004). The prevalence of psychiatric disorder among a community sample of crack cocaine users: An exploratory study with practical implications. The Journal of Nervous and Mental Disease, 192, 503-507.
26. Faruque, S., Edlin, B. R., McCoy, C. B., Word, C. O., Larsen, S. A., Schmid, D. S., et al. (1996). Crack cocaine smoking and oral sores in three inner-city neighborhoods. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, 87-92.
27. Fischer, B., & Allard, C. (2007). Feasibility study on 'supervised drug consumption' options in the City of Victoria. Victoria: Centre for Addictions Research of BC (CAR-BC).
28. Fischer, B., Chin, A., Kuo, I., Kirst, M., & Vlahov, D. (2002). Canadian illicit opiate users' views on methadone and other opiate prescription treatment: An exploratory qualitative study. Substance Use and Misuse, 37, 495-522.
29. Fischer, B., & Coghlan, M. (2007). Crack in North American cities: The neglected 'epidemic'. Addiction, 102, 1340-1341.
30. Fischer, B., Haydon, E., Rehm, J., Krajden, M., & Reimer, J. (2004). Injection drug use and the hepatitis C virus: Considerations for a targeted treatment approach - The case study of Canada. Journal of Urban Health, 81, 428-447.
31. Fischer, B., Kendall, P., & Allard, C. (2008a). The case for a supervised drug consumption site trial in Victoria, British Columbia. BC Medical Journal, 50, 130-131.
32. Fischer, B., Monga, N., & Manzoni, P. (2005b). Differences between co-users of cocaine and crack among Canadian illicit opioid users. Sucht, 51, 217-224.
33. Fischer, B., Powis, J., Firestone Cruz, M., Rudzinski, K., & Rehm, J. (2008b). Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. European Journal of Gastroenterology & Hepatology, 20, 29-32.
34. Fischer, B., Rehm, J., Brissette, S., Brochu, S., Bruneau, J., el-Guebaly, N., et al. (2005a). Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). Journal of Urban Health, 82, 250-266.
35. Fischer, B., Rehm, J., Patra, J., & Firestone Cruz, M. (2006a). Changes in illicit opioid use profiles across Canada. Canadian Medical Association Journal, 175, 1-3.
36. Fischer, B., Rehm, J., Patra, J., Kalousek, K., Haydon, E., Tyndall, M., et al. (2006b). Crack across Canada: Comparing crack and non-crack users in a multi-city cohort of opioid and other street drug users. Addiction, 101, 1760-1770.
37. Galea, S., Rudenstine, S., & Vlahov, D. (2005). Drug use, misuse, and the urban environment. Drug and Alcohol Review, 24, 127-136.
38. Garrity, T. F., Leukefeld, C., Carlson, R. G., & Falck, R. S. (2007). Physical health, illicit drug use, and demographic characteristics in rural stimulant users. The Journal of Rural Health, 23, 99-107.
39. Gorelick, D., Gardner, E., & Xi, Z. (2004). Agents in development for the management of cocaine abuse. Drugs, 64, 1547-1573.
40. Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004). Agonist-like replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors, 29, 1439-1464.
41. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 61, 807-816.
42. Haydon, E., & Fischer, B. (2005). Crack use as a public health problem in Canada - call for an evaluation of 'safer crack use kits'. Canadian Journal of Public Health, 96, 185-188.
43. Health Canada (2004). I-Track: Enhanced surveillance of risk behaviours among injecting drug users in Canada (pilot survey report). Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada.
44. Health Canada (2006). I-Track: Enhanced surveillance of risk behaviours among injecting drug users in Canada - Phase I report. Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention, Health Canada.
45. Hedrich, D. (2004). European report on drug consumption rooms. Lisbon: European Monitoring Centre on Drugs and Drug Addiction (EMCDDA).
46. Howard, A., Klein, R., Schoenbaum, E., & Gourevitch, M. (2002). Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clinical Infectious Diseases, 35, 1183-1190.
47. Hwang, S. (2001). Homelessness and health. Canadian Medical Association Journal, 164, 229-232.
48. James, D. (2007). Harm reduction policy background paper. Alberta: Alberta Alcohol and Drug Abuse Commission (AADAC).
49. Judd, A., Parry, J., Hickman, M., McDonald, T., Jordan, L., Lewis, K., et al. (2003). Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. Journal of Medical Virology, 71, 49-55.
50. Kaye, S., & Drake, S. (2004). Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. Addiction, 99, 1315-1322. (Pubitemid 39330936)
51. Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., et al. (2007). Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug & Alcohol Dependence, 87, 39-45.
52. Khandor, E., & Mason, K. (2008). The street health report 2007, Research bulletin #3: Homelessness & crack use (Rep. No. http://www.streethealth.ca/publications.htm). Toronto: Street Health.
53. Khantzian, E. J. (1997). The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Harvard Review of Psychiatry, 4, 231-224.
54. Kresina, T. F., Normand, J., Khalsa, J., Mitty, J., Flanigan, T., & Francis, H. (2004). Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities. Clinical Infectious Diseases, 38, S398-S401.
55. Kringlen, E., Torgersen, S., & Cramer, V. (2006). Mental illness in a rural area. Social Psychiatry and Psychiatric Epidemiology, 41, 173-179.
56. Latkin, C., Mandell, W., Vlahov, D., Knowlton, A., Oziemkowska, M., & Celentano, D. (1995). Self-reported reasons for needle sharing and not carrying bleach among injection drug users in Baltimore, Maryland. Journal of Drug Issues, 25, 865-870.
57. Lejuez, C., Bornovalova, M., Daughters, S., & Curtin, J. (2005). Differences in impulsivity and sexual risk behaviour among inner-city crack/cocaine users and heroin users. Drug & Alcohol Dependence, 77, 169-175.
58. Leonard, L., DeRubeis, E., Pelude, L., Medd, E., Birkett, N., & Seto, J. (2008). ''I inject less as i have easier access to pipes'' Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. International Journal of Drug Policy, 19, 255-264.
59. Leonhardt, K., Gentile, F., Gilbert, B., & Aiken, M. (1994). A cluster of tuberculosis among crack house contacts in San Mateo County, California. American Journal of Public Health, 84, 1834-1836.
60. Loftis, J. M., Matthews, A. M., & Hauser, P. (2006). Psychiatric and substance use disorders in individuals with hepatitis C: Epidemiology and management. Drugs, 66, 155-74.
61. Logan, T. K., & Leukefeld, C. (2000). Sexual and drug use behaviors among female crack users: A multi-site sample. Drug and Alcohol Dependence, 58, 237-245.
62. Malchy, L., Bungay, V., & Johnson, J. (2008). Documenting practices and perceptions of 'safer' crack use: A Canadian pilot study. International Journal of Drug Policy, 19, 339-341.
63. Manzoni, P., Brochu, S., Fischer, B., & Rehm, J. (2006). Determinants of property crime among illicit opiate users outside of treatment across Canada. Deviant Behaviour, 27, 351-376.
64. Maranda, M., Han, C., & Rainone, G. (2004). Crack cocaine and sex. Journal of Psychoactive Drugs, 36, 315-322.
65. McElroy, P., Rothenberg, R., Varghese, R., Woodruff, R., Minns, G., Muth, S., et al. (2003). A network-informed approach to investigating a tuberculosis outbreak: Implications for enhancing contact investigations. International Journal of Tuberculosis and Lung Disease, 7, S486-S493.
66. McMahon, J., & Tortu, S. (2003). A potential hidden source of hepatitis C infection among noninjecting drug users. Journal of Psychoactive Drugs, 35, 455-460.
67. Metsch, L. R., & McCoy, C. B. (1999). Drug treatment experiences: Rural and urban comparisons. Substance Use & Misuse, 34, 763-784.
68. Metsch, L., McCoy, H., McCoy, C., Miles, C., Edlin, B., & Pereyra, M. (1999). Use of health care services by women who use crack cocaine. Women and Health, 30, 35-51.
69. Micallef, J., Kaldor, J., & Dore, J. (2006). Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis, 13, 34-41.
70. National Institute on Drug Abuse (NIDA) (2005). NIDA info facts: Crack and cocaine (Rep. No. http://www.nida.nih.gov/Infofacts/cocaine.html). Rockville: NIDA.
71. Newbold, K. B. (1998). Problems in search of solutions: Health and Canadian aboriginals. Journal of Community Health, 23, 59-74.
72. O'Byrne, P., & Holmes, D. (2008). Evaluating crack pipe distribution in Canada: A systems change case study. Addiction Research and Theory, 16, 181-192.
73. Ouellet, L., Thorpe, L., Huo, D., Bailey, S., Jimenez, A., Johnson, W., et al. (2000). Prevalence and incidence of HIV among out-of-treatment injecting drug users, Chicago 1994-1996. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 25, 443-450.
74. Palepu, A., Strathdee, S. A., Hogg, R. S., Anis, A. H., Rae, S., Cornelisse, P. G. A., et al. (1999). The social determinants of emergency department and hospital use by injection drug users in Canada. Journal of Urban Health, 76, 409-418.
75. Pollini, R., Brouwer, K., Lozada, R., Ramos, R., Cruz, M., Magis-Rodriguez, C., et al. (2008). Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction, 103, 101-108.
76. Porter, J., & Bonilla, L. (1993). Crack users' cracked lips: An additional HIV risk factor. American Journal of Public Health, 83, 1490-1491.
77. Porter, J., Bonilla, L., & Drucker, E. (1997). Methods of smoking crack as a potential risk factor for HIV infection: Crack smokers' perceptions and behavior. Contemporary Drug Problems, 24, 219-347.
78. Robertson, E., Sloboda, Z., Boyd, G., Beatty, L., & Kozel, N. E. (1997). Rural substance abuse: State of knowledge and issues [NIDA Research Monograph Series 168]. Rockville, MD: National Institute on Drug Abuse.
79. Ross, M. W., Hwang, L. Y., Zack, C., Bull, L., & Williams, M. L. (2002). Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. International Journal of STD and AIDS, 13, 769-774.
80. Roy, E., Haley, N., Leclerc, P., Boivin, J. F., Cedras, L., & Vincelette, J. (2001). Risk factors for hepatitis C virus infection among street youths. Canadian Medical Association Journal, 165, 557-560.
81. Roy, K. M., Goldberg, D. J., Hutchinson, S., Cameron, S. O., Wilson, K., & MacDonald, L. (2004). Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users. Journal of Medical Virology, 74, 62-66.
82. Scheinmann, R., Hagan, H., Lelutiu-Weinberger, C., Stern, R., Des, J., Flom, P. L., et al. (2007). Non-injection drug use and Hepatitis C virus: A systematic review. Drug & Alcohol Dependence, 89, 1-12.
83. Shannon, K., Ishida, T., Morgan, R., Bear, A., Oleson, M., Kerr, T., et al. (2006). Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users. Harm Reduction Journal, 3, 1-8.
84. Shannon, K., Rusch, M., Morgan, R., Oleson, M., Kerr, T., & Tyndall, M. W. (2008). HIV and HCV prevalence and gender-specific risk profiles of crack cociane smokers and dual users of injection drugs. Substance Use & Misuse, 43, 521-534.
85. Small, D., & Drucker, E. (2008). Return to Galileo? The inquisition of the International Narcotic Control Board. Harm Reduction Journal, 5, available at http://www.harmreductionjournal.com/ contents/5/1/16.
86. SPSS Inc (2007). SPSS for Windows (Version 15.0) [Computer software]. Chicago: SPSS Inc.
87. Steel, E., & Haverkos, H. (1992). AIDS and drug abuse in rural America: Policy practice and research briefs. The Journal of Rural Health, 8, 70-73.
88. Symington, A. (2007). Ottawa: Crack pipe program cancelled by city council. HIV/AIDS Policy and Law Review, 12, 29-30.
89. Taubes, T., Galanter, M., Dermatis, H., & Westreich, L. (1998). Crack cocaine and schizophrenia as risk factors for PPD reactivity in the dually diagnosed. Journal of Addictive Diseases, 17, 63-74.
90. The Canadian Press (2007, December 12). Crack pipe sharing increases Hep C spread: Study. Canada: CTV News.
91. Tortu, S., McMahon, J., Pouget, E., & Hamid, R. (2004). Sharing of noninjection drug-use implements as a risk factor for Hepatitis C. Substance Use and Misuse, 39, 211-224.
92. Tyndall, M., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M., et al. (2003). Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS, 17, 887-893.
93. Urbanoski, K., Rush, B., Wild, T., Bassani, D., & Castel, S. (2007). Use of mental health care services by Canadians with co-occurring substance dependence and mental disorders. Psychiatric Services, 58, 962-969.
94. Vicary, J., Doebler, M., Bridger, J., Gurgevich, E., & Deike, R. (1996). A community systems approach to substance abuse prevention in a rural setting. The Journal of Primary Prevention, 16, 303-318. (Pubitemid 26049504)
95. Villano, S., Vlahov, D., Nelson, K., Cohn, S., & Thomas, D. (1999). Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology, 29, 908-914.
96. Wallace, J. I., Porter, J., Weiner, A., & Steinberg, A. (1997). Oral sex, crack smoking, and HIV infection among female sex workers who do not inject drugs. American Journal of Public Health, 87, 470.
97. Watkins, K. E., Hunter, S. B., Wenzel, S. L., Tu, W., Paddock, S. M., Griffin, A., et al. (2004). Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. The American Journal of Drug and Alcohol Abuse, 30, 749-764.
98. Werb, D., Kerr, T., DeBeck, K., Li, K., Montaner, J., & Wood, E. (2008). Modeling crack use trends over 10 years in a Canadian setting. Cracked but not broken conference, April 18th-20th, 2008 Vancouver, Canada.
99. Wilkinson, M., Crawford, V., Tippet, A., Jolly, F., Turton, J., Sims, E., et al. (2009). Community-based treatment for chronic hepatitis C in drug users: High rates of compliance with therapy despite ongoing drug use. Alimentary Pharmacology and Therapeutics, 29, 29-37.
100. Wood, E., Spittal, P. M., Kerr, T., Small, W., Tyndall, M. W., O'Shaughnessy, M. V., et al. (2003). Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Canadian Journal of Public Health, 94, 355-9.